Renalytix Plc (RNLX) Gross Profit Margin starting from the first quarter 2024 to first quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Renalytix Plc  (RNLX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Renalytix Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RNLX Gross Profit Margin (Sep 30 2024)
Q1 		(Jun 30 2024)
Q4 		(Mar 31 2024)
Q3 		(Dec 31 2023)
Q2 		(Sep 30 2023)
Q1
Y / Y Revenue Change 13.73 %
Seq. Revenue Change -10.92 %
Revenue In Millions $0.52
Gross Profit Margin 19.16 %
Gross Profit Margin Total Ranking # 3183
Gross Profit In Millions $0.10
Y / Y Gross Profit Change -
Seq. Gross Profit Change 177.78 %


Commenting First Quarter 2024 Gross Profit Margin
Renalytix Plc achieved Gross Profit of $0 millions compare to Gross Loss of $0.04 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q1 of -10.92 % Renalytix Plc managed to reduce Cost of Sales and increase Gross Profit by 177.78 % to $0 millions. Gross Profit Margin grew to 19.16 %, below company average Gross Profit Margin.


Observing first quarter 2024 results within Medical Laboratories industry 28 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 3183, from total ranking in the previous quarter at 3570.
Learn about Gross Margin
RNLX's Gross Profit Margin first quarter 2024 Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 456
Overall # 3138

Gross Profit Margin Statistics
High Average Low
72.7 % 31.9 % 6.14 %
0   (Jun 30 2024)


RNLX Gross Income Trends • More of RNLX's Profitabilty Ratios • RNLX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
RNLX's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
RNLX's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for RNLX's Competitors
Gross Profit Margin Profit Margin for Renalytix Plc's Suppliers
Gross Profit Margin Profit Margin for RNLX's Customers

You may also want to know
RNLX's Annual Growth Rates RNLX's Profitability Ratios RNLX's Asset Turnover Ratio RNLX's Dividend Growth
RNLX's Roe RNLX's Valuation Ratios RNLX's Financial Strength Ratios RNLX's Gross Profit Growth
RNLX's Roa RNLX's Inventory Turnover Ratio RNLX's Growth Rates RNLX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2024, within Medical Laboratories Industry Gross Profit MarginSep 30 2024 MRQ Gross ProfitSep 30 2024 MRQ Revenue
Billiontoone Inc   52.62 %$ 20.215  Millions$ 38.419  Millions
Ge Healthcare Technologies Inc   49.91 %$ 2,026.000  Millions$ 4,059.000  Millions
Ispecimen inc   41.62 %$ 1.108  Millions$ 2.662  Millions
Psychemedics Corporation  40.46 %$ 2.039  Millions$ 5.039  Millions
Fulgent Genetics Inc   37.83 %$ 26.771  Millions$ 70.771  Millions
Iqvia Holdings Inc   35.37 %$ 1,378.000  Millions$ 3,896.000  Millions
Charles River Laboratories International inc   34.56 %$ 349.021  Millions$ 1,009.763  Millions
Personalis Inc   34.02 %$ 8.745  Millions$ 25.709  Millions
Quest Diagnostics Inc  32.60 %$ 811.000  Millions$ 2,488.000  Millions
Medpace Holdings Inc   31.69 %$ 169.008  Millions$ 533.317  Millions
American Shared Hospital Services  31.35 %$ 1.370  Millions$ 4.370  Millions
Labcorp Holdings Inc   27.56 %$ 904.400  Millions$ 3,282.000  Millions
Fortrea Holdings Inc   21.97 %$ 148.300  Millions$ 674.900  Millions
Renalytix Plc  19.16 %$ 0.100  Millions$ 0.522  Millions
Bionexus Gene Lab Corp   12.41 %$ 0.327  Millions$ 2.630  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.